MSCI TAIWAN (STRD)

Index

End-of-day quote MSCI 10:00:00 2024-05-20 am EDT 5-day change 1st Jan Change
746.2 USD +0.01% Intraday chart for MSCI TAIWAN (STRD) +3.75% +16.82%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
CHINA'S TAIWAN AFFAIRS OFFICE, ON U.S., OTHER COUNTRIES ATTENDIN… RE
Taiwan’s Manufacturing Output Rises 4.6% in Q1 MT
Taiwan's Export Orders Jump 11% in April MT
China to Launch Anti-Dumping Investigation on Chemical Imports from EU, US, Taiwan, Japan MT
Boeing, General Dynamics Reportedly Added to China's Unreliable Entity List MT
North American Morning Briefing : Stocks Drift as Metals Hover Around Records DJ
Taiwan April export orders grow at fastest pace in 2 years RE
New Taiwan President Lai urges China to stop threats RE
Factbox-Key facts on Taiwan-China relations as new Taiwan president takes office RE
China Hints at Possible Retaliation Against EU Probes DJ
Taiwan's new president sworn in amid China tensions RE
New Taiwan president to take office facing angry China RE
Lai Ching-te sworn in as Taiwan's new president RE
Foreign dignitaries attending Taiwan president inauguration RE
China launches anti-dumping probe into EU, US, Japan, Taiwan plastics RE
Taiwan's new president to extend goodwill to China in inauguration speech RE
REUTERS-SCHEDULE/… RE
China launches anti-dumping probe into EU, US, Japan, Taiwan chemicals RE
Incoming Taiwan president Lai to pledge steady approach to relationship with China RE
Taiwan lawmakers brawl over parliament reforms RE
Taiwan's new president set to face an angry China RE
China criticises US in military unit's call with US defence official, says China ministry RE
Tracking China's 'grey zone' balloon flights over Taiwan RE
Taiwan Kong King's Q1 Profit Plunges 61% MT
Factbox-What is Putin and Xi's 'new era' strategic partnership? RE
  1. Stock Market
  2. Indexes
  3. MSCI TAIWAN (STRD)
  4. News MSCI TAIWAN (STRD)
  5. US FDA OKs Acepodia's Investigational New Drug Application for Cancer Treatment
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW